RenovoRx, Inc.
RNXT · NASDAQ
Bulios Fair Price
$1.56
7.7% downside
Trenutna cena
$1.69
Po podatkih Bulios Fair Price je delnica RNXT trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
RenovoRx, Inc. (RNXT) is an American biotechnology company focused on developing innovative therapies for the treatment of hard-to-treat cancers. The company is developing advanced targeted treatment technologies that enable the direct delivery of chemotherapy to tumors with minimal impact on surrounding healthy tissues. The company's flagship product is the RenovoTAMP™ system, designed to improve the efficacy and reduce the side effects of cancer treatment. RenovoRx aims to provide new treatment options for patients with limited therapeutic alternatives. RenovoRx, Inc. (RNXT) shares could be an interesting choice for investors looking for opportunities in the biotechnology sector and innovative treatment technologies.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Shaun R. Bagai
Employees
17
Headquarters
Mountain View
Prihajajoči dogodki
Earnings
Upcoming earnings report